maximal treadmill exercise testing at 1 , 3 and 8 hours was used to assess the onset , duration and antianginal efficacy of the dihydropyridine slow channel calcium-blocking agent , nisoldipine , in an oral dose range of 5 , 10 and 20 mg .
C2945601
dihydropyridine
C0028116
nisoldipine